Congratulations to the ASPIRE award winner 2023 Adrian Shields #IPIC2023#IPICmoment

Fantastic talk by Dr. Pere Soler-Palacín about new tools for PID diagnosis #PID #IPIC2023 #IPICmoment ⁦BCN PID Foundation⁩ ⁦Immunologia Hospital Vall d'Hebron⁩

How can artificial intellingence help detect patients at risk of primary immunodeficiency? Dr. Nick Rider @NRider70 explained it to us at #IPIC2023 #IPICmoment . Excellent talk!

It was a pleasure to meet the three ASPIRE award winners Dr. Laia Alsina (2021), Dr. Emily Edwards (2022) and Dr. Adrian Shields (2023) at #IPIC2023 #IPICmoment Laia Alsina Manrique de Lara Dr Emily Edwards Adrian Shields

Exploring Gastric Cancer Genetics: A Turning Point in Common Variable Immunodeficiency - ScienceDirect sciencedirect.com/science/articl…

Congratulations Dr. Cunningham-Rundles on this Award!

Patients with immunodeficiency are often undiagnosed or experience marked delay in detection. #AI to the rescue. science.org/doi/10.1126/sc… Science Translational Medicine Manish Butte UCLA

Opening the CIS meeting 2024 with a Tribute to Vicki Modell by Dr. Orange CIS @jordanorange #CIS2024 #PIDD

The legendary Dr. Cunningham-Rundles sharing her pearls of wisdom about IG replacement therapy ⁦CIS⁩

Do not miss it!!! #PrimaryImmunodeficiencies Hospital del Mar

Economic Impact of Immunoglobulin replacement therapy in secondary immunodeficiency to hematological cancer. A single center observational study frontiersin.org/journals/immun…

🌍 Our first day at the Global Stakeholders Summit is actively unfolding with vibrant discussions, exploring new horizons and innovations for global progress in PIDs! #GlobalStakeholdersSummit #PIDs #Innovation

Engineered T cells (CAR T) is a transformative Rx for cancer and emerging for autoimmune diseases. A meta-analysis of >7,600 patients in 18 clinical trials and 28 real-world studies highlights the risk of infection during follow-up as the principal cause of non-relapse mortality

Fantastic talks by Dr. Jacques Rivière and Dr. Eleonora Gambineri about how truncate time to immunodeficiency diagnosis at #ESID2024 #Grifols symposium today

Dissecting the crossovers between SID to B hematological malignancy & IEI at ESID San Carlos Immunology team #somosclinico

Excited to share our latest findings on the complex challenges of diagnosing PID in the context of SID linked to B-cell malignancies. Stay tuned for insights! link.springer.com/article/10.100…

Do not miss this #postdoctoral opportunity in our team!

The IUIS Inborn Errors Update is online!

The long-awaited 2024 update and phenotypic classification are here: